Fabien Koutchekian, founder of Genomines, spent 14 months raising $45 million from 12 funds, including Engine Ventures and Hyundai. His journey illustrates the unpredictable nature of fundraising, which often involves endless conversations, ghosting by investors, and a lot of rejection. Despite having a solid business model—using hyperaccumulator plants to extract nickel from soil—Koutchekian faced significant psychological challenges during the process. He initially turned down a lower offer from one fund, only to find the door closed when he tried to return. This moment was pivotal, not because of the lost opportunity, but because it tested his conviction and mental resilience. Koutchekian’s approach to overcoming this doubt involved heavy psychological work, including meditation and visualization techniques. He recognized that a founder's belief in their vision can significantly influence investor perception. When he shifted the narrative focus of Genomines from full refining to just extraction, it wasn't a pivot but rather a refined emphasis that addressed investor concerns. They learned to recognize signals from investors that indicated where to concentrate their messaging without altering the core business. Another key strategy was building a comprehensive Q&A document to address investor pushback. By compiling feedback and concerns into hundreds of pages, Genomines equipped themselves to counter doubts effectively. They even created tailored presentations to debunk myths about their technology. This approach highlights the importance of understanding investor psychology and adapting narratives to clarify value propositions.